Showing results (1-10 of 258) with videos related to
Sort By:
Pageof 26
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 20, 2022
[Advanced Medical Care]Hirotsugu KenmotsuGan to Kagaku Ryoho. Cancer & Chemotherapy|February 10, 2023
[Difference in Chemotherapy for Lung Cancer between Asian and Caucasian]Hirotsugu KenmotsuGan to Kagaku Ryoho. Cancer & Chemotherapy|May 9, 2020
[Immune Checkpoint Inhibitor Induced Pneumonitis and Its Management]Hiroaki Kodama, Hirotsugu KenmotsuInternal Medicine (Tokyo, Japan)|September 18, 2010
Recent development of molecular-targeted drugs in lung cancerNagahiro Saijo, Hirotsugu KenmotsuCancer Science|March 3, 2015
Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western doseHirotsugu Kenmotsu, Yusuke TanigawaraGan to Kagaku Ryoho. Cancer & Chemotherapy|July 26, 2018
[Pneumonitis Induced by Immune Checkpoint Inhibitors]Eriko Miyawaki, Hirotsugu KenmotsuClinical Lung Cancer|July 3, 2017
Randomized Phase III Study of Cisplatin With Pemetrexed and Cisplatin With Vinorelbine for Completely Resected Nonsquamous Non-Small-Cell Lung Cancer: The JIPANG Study ProtocolNobuyuki Yamamoto, Hirotsugu Kenmotsu, Takeharu Yamanaka, et al.Investigational New Drugs|June 30, 2017
Chemotherapy-induced cardiomyopathy caused by PemetrexedTakuya Oyakawa, Kei Iida, Masatoshi Kusuhara, et al.Cancers|August 27, 2021
Current Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Interstitial PneumoniaSatoshi Ikeda, Terufumi Kato, Hirotsugu Kenmotsu, et al.Investigational New Drugs|September 8, 2016
Osimertinib-induced interstitial lung disease after treatment with anti-PD1 antibodyNobuaki Mamesaya, Hirotsugu Kenmotsu, Mineo Katsumata, et al.Pageof 26